Kulkarni Cancer & Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -62.47%
- Profit Growth -223.95%
- Ebitda -139.46%
- Net Worth -9.90%
- Total Assets -11.98%
About Kulkarni Cancer & Eye Hospital
Kulkarni Cancer & Eye Hospital Private Limited (KCEHPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 May 2009 and has a history of 15 years and nine months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shantanu Kulkarni and Gauri Kulkarni serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110MH2009PTC192276
- Company No.
192276
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kulkarni Cancer & Eye Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shantanu Kulkarni  | Director | 08-May-2009 | Current |
| Gauri Kulkarni | Director | 08-May-2009 | Current |
Financial Performance of Kulkarni Cancer & Eye Hospital.
Kulkarni Cancer & Eye Hospital Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 62.47% decrease. The company also saw a substantial fall in profitability, with a 223.95% decrease in profit. The company's net worth dipped by a decrease of 9.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kulkarni Cancer & Eye Hospital?
In 2017, Kulkarni Cancer & Eye Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kulkarni Cancer & Eye Hospital?
Unlock and access historical data on people associated with Kulkarni Cancer & Eye Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kulkarni Cancer & Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kulkarni Cancer & Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.